ESC 365 - Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches

HFA Premium Access

Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches

Session: Chronic heart failure - treatment 3

Topic: Pharmacotherapy

Speaker: Mr D. Ferreira (Lisbon, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Mr Diogo Ferreira

Santa Maria Hospital - CHULN, Lisbon (Portugal)

0 follower

3 more presentations in this session

Analysis of the PARAGON-HF study results using win ratio

Speaker: Doctor W. Kim (Seoul, KR)

Projected lifetime benefits of sacubitril/valsartan on event-free survival in patients with HFmrEF and HFpEF in the PARAGON-HF trial

Speaker: Doctor A. Foa' (Boston, US)

Feasibility, efficacity and safety of a fast up-titration program of heart failure treatments in real-life practice.

Speaker: Miss L. Blasi (Toulouse, FR)

Access the full session

Chronic heart failure - treatment 3

Speakers: Mr D. Ferreira, Doctor W. Kim, Doctor A. Foa', Miss L. Blasi

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources